Overview
Hereditary bullous dystrophy, macular type (also known as bullous dystrophy of the skin, macular type, or sometimes referred to as a form of epidermolysis bullosa) is an extremely rare inherited skin condition. In this disease, the skin is unusually fragile and forms blisters (bullae) with minimal friction or trauma. What makes this particular type distinct is the development of flat, discolored patches on the skin called macules, which may appear after blisters heal. These macules can be lighter or darker than the surrounding skin and tend to persist over time. The condition typically begins early in life, often at birth or during infancy, when parents may notice that the baby's skin blisters easily during normal handling or diaper changes. Over time, repeated blistering and healing can lead to scarring and permanent changes in skin pigmentation. The severity can vary between affected individuals, even within the same family. Because this is such a rare condition, treatment options are mainly supportive and focused on preventing skin trauma, managing blisters when they occur, preventing infections, and promoting wound healing. There is currently no cure. Careful skin care, protective bandaging, and monitoring for complications such as skin infections are the mainstays of management. Genetic counseling is recommended for affected families to understand the inheritance pattern and recurrence risk.
Key symptoms:
Fragile skin that blisters easilyBlisters forming with minor friction or traumaFlat discolored patches (macules) on the skinChanges in skin color after blisters healScarring from repeated blisteringSkin erosions or open soresSkin sensitivity and tendernessRisk of skin infections at blister sitesPossible nail abnormalitiesPatches of lighter or darker skin pigmentation
Clinical phenotype terms (23)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hereditary bullous dystrophy, macular type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary bullous dystrophy, macular type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hereditary bullous dystrophy, macular type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary bullous dystrophy, macular type.
Community
No community posts yet. Be the first to share your experience with Hereditary bullous dystrophy, macular type.
Start the conversation →Latest news about Hereditary bullous dystrophy, macular type
No recent news articles for Hereditary bullous dystrophy, macular type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact type and severity of my child's blistering condition?,Is genetic testing available to confirm the diagnosis, and should other family members be tested?,What is the best daily skin care routine to prevent blisters?,What signs of infection should I watch for, and when should I seek emergency care?,Are there any clinical trials or new treatments being studied for this condition?,How might this condition change as my child grows older?,Can you refer us to a wound care specialist and a genetic counselor?
Common questions about Hereditary bullous dystrophy, macular type
What is Hereditary bullous dystrophy, macular type?
Hereditary bullous dystrophy, macular type (also known as bullous dystrophy of the skin, macular type, or sometimes referred to as a form of epidermolysis bullosa) is an extremely rare inherited skin condition. In this disease, the skin is unusually fragile and forms blisters (bullae) with minimal friction or trauma. What makes this particular type distinct is the development of flat, discolored patches on the skin called macules, which may appear after blisters heal. These macules can be lighter or darker than the surrounding skin and tend to persist over time. The condition typically begins
How is Hereditary bullous dystrophy, macular type inherited?
Hereditary bullous dystrophy, macular type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary bullous dystrophy, macular type typically begin?
Typical onset of Hereditary bullous dystrophy, macular type is neonatal. Age of onset can vary across affected individuals.